Muller Fabbri to RNA, Neoplasm
This is a "connection" page, showing publications Muller Fabbri has written about RNA, Neoplasm.
Connection Strength
1.690
-
Fanini F, Bandini E, Plousiou M, Carloni S, Wise P, Neviani P, Murtadha M, Foca F, Fabbri F, Vannini I, Fabbri M. MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer. Int J Mol Sci. 2021 Dec 12; 22(24).
Score: 0.731
-
Vannini I, Fanini F, Fabbri M. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem. 2013 Jul; 46(10-11):918-25.
Score: 0.396
-
Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 2013 Feb; 10(2):169-74.
Score: 0.394
-
Ludwig S, Sharma P, Wise P, Sposto R, Hollingshead D, Lamb J, Lang S, Fabbri M, Whiteside TL. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. Int J Mol Sci. 2020 Nov 13; 21(22).
Score: 0.170